# Sildenafil

## Revatio 20mg

| 藥物代碼           | OREV                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Pulmonary arterial hypertension (PAH)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 副作用             | >10%:Flushing (10% to 19%), Headache (16% to 46%), Dyspepsia (3% to 17%; dose-related), Visual disturbance (2% to 11%; including vision color changes, blurred vision, and photophobia; dose-related), Epistaxis (9% to 13%)2% to 10%: Insomnia (?7%), dizziness (2% to 4%), paresthesia (?3%), Erythema (6%), skin rash (1% to 3%), Diarrhea (3% to 9%), gastritis (?3%), nausea (2% to 3%), Urinary tract infection (3%), Increased liver enzymes (2% to 10%), Myalgia (2% to 7%), back pain (3% to 4%), Nasal congestion (4% to 9%), exacerbation of dyspnea (?7%), nasal congestion (4%), rhinitis (4%), sinusitis (3%), Fever (6%) |
| 禁忌               | Hypersensitivity to sildenafil or any component of the formulation; concurrent use (regularly/intermittently) of organic nitrates in any form (eg, nitroglycerin, isosorbide dinitrate); concomitant use of riociguat (a guanylate cyclase stimulator).                                                                                                                                                                                                                                                                                                                                                                                 |
| 藥物保存方式       | 儲存於25°C                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 用法用量           | The recommended dose is 20 mg TID and the interval is 4-6 hours. In clinical trials, the use of higher doses does not produce greater efficacy, so the use of more than 20 mg three times a day is not recommended.                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 肝功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 腎功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 懷孕用藥危分級     | 尚未確立                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 孕期用藥建議       | No (Limited) Human Data - animal data suggest low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 哺乳期用藥建議     | No (Limited) Human Data - Potential Toxicity 無(很少)資料 - 避免使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 注射劑給藥建議途徑 | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 注意事項           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |

